arrow
H

Harry J.M. Groen

Rijksuniversiteit Groningen
H指数:89
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population

改进肺癌筛查选择:风险模型与传统标准在西欧一般人群中的比较分析

Cancers
IF4.4
2026-02-260
OAAI
The SAVE FGR study: Short term variation Analysis versus Visual Evaluation of cardiotocography in early-onset Fetal Growth Restriction to trigger expedited birth - study protocol for a stepped wedge cluster randomized trial

SAVE FGR研究:早期胎儿生长受限的胎心监护图短期变异分析对比视觉评估以触发加速分娩——分步楔形集群随机试验研究方案

2026-02-210
OAAI
DuTOC: The prospective Dutch Thoracic Oncology Cohort: A nationwide infrastructure to collect clinical data, PROMS and bio-material to support thoracic oncology studies

DuTOC:荷兰胸癌前瞻性队列研究:一个全国性的基础设施,用于收集临床数据、患者报告结局测量(PROMs)和生物材料,以支持胸癌研究

2025-08-260
OAAI
Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study

基于细胞自由DNA的下一代测序无法区分接受免疫检查点抑制剂治疗的非小细胞肺癌患者中的寡进展和全身进展——一项探索性研究

2025-08-210
PRE
Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease

基于模型的联合低剂量计算机断层扫描筛查肺癌、慢性阻塞性肺疾病和心血管疾病的成本-效用分析

2025-02-011
OAAI
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

非小细胞肺癌中EGFR外显子20变异的异质性和目前可用治疗的 (前) 临床活性的综合概述

2023-11-018
OA